IXC invex therapeutics ltd

Ann: Invex Granted Type C Meeting with FDA, page-7

  1. 365 Posts.
    lightbulb Created with Sketch. 30
    Yes and written responses to be provided mid June.
    The Chairman is quoted as being "pleased', so obviously there will be some clarity achieved as a result of the FDA feedback and we can all move on with 1 or 2 trials.
    Share price sitting at these levels is very frustrating though.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.1¢
Change
0.000(0.00%)
Mkt cap ! $6.839M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 41290 8.8¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 9000 1
View Market Depth
Last trade - 16.21pm 04/07/2025 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.